Manimozhiyan Arumugam

University of Copenhagen — Denmark

Biochemistry, Genetics and Molecular Biology · Life Sciences

56h-index75.1kcitations159works23.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gut microbiota and health(88), Diet and metabolism studies(40), Liver Disease Diagnosis and Treatment(21), Clostridium difficile and Clostridium perfringens research(17), Genomics and Phylogenetic Studies(15)

Publications152 total

The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial
Nature Communications·2025· 4 citedOpen Access
Microbial signatures in oral sites of patients with primary Sjögren’s syndrome: Association with salivary gland hypofunction
The Journal of Microbiology·2025Open Access
Housing matters: Experimental variables shaping metabolism in obese mice
Molecular Metabolism·2025· 1 citedOpen Access
43P Association between gut microbiome and breast cancer recurrence
ESMO Open·2025Open Access
Microbiome testing in Europe: navigating analytical, ethical and regulatory challenges
Microbiome·2024· 17 citedOpen Access
Author Correction: Examining the healthy human microbiome concept
Nature Reviews Microbiology·2024· 5 citedOpen Access
International consensus statement on microbiome testing in clinical practice
˜The œLancet. Gastroenterology & hepatology·2024· 58 citedOpen Access
Coffee consumption is associated with intestinal Lawsonibacter asaccharolyticus abundance and prevalence across multiple cohorts
Nature Microbiology·2024· 55 citedOpen Access
Fecal microbial load is a major determinant of gut microbiome variation and a confounder for disease associations
Cell·2024· 69 citedOpen Access
Sexual Dimorphism in the Immunometabolic Role of Gpr183 in Mice
Journal of the Endocrine Society·2024· 1 citedOpen Access
Examining the healthy human microbiome concept
Nature Reviews Microbiology·2024· 112 citedOpen Access
State of the art and the future of microbiome-based biomarkers: a multidisciplinary Delphi consensus
The Lancet Microbe·2024· 26 citedOpen Access
Genome-wide association study identifies host genetic variants influencing oral microbiota diversity and metabolic health
Scientific Reports·2024· 15 citedOpen Access
WED-548 Rifaximin-alpha acts through increased abundance of Lactobacillus spp. in murine models of chronic liver disease
Journal of Hepatology·2024
OS-071-YI Variation of the human microbiome across multiple body sites and temporal dynamics in different stages of decompensated cirrhosis
Journal of Hepatology·2024
THU-055 Differential impact of proton pump inhibitors, statins, and nonselective beta-blockers on survival in different stages of chronic liver disease
Journal of Hepatology·2024
OS-072-YI Identifying patterns of steatotic liver disease severity: a multiomic analysis of 834 distinct omics features from healthy to end-stage liver disease in 854 individuals
Journal of Hepatology·2024
Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases
Journal of Hepatology·2024· 49 citedOpen Access
Fecal microbial load is a major determinant of gut microbiome variation and a confounder for disease associations
2024· 12 citedOpen Access
Infections increase the risk of decompensation and death in patients with early alcohol-related liver disease
JHEP Reports·2024· 6 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Peer Bork(29), Torben Hansen(21), Jeroen Raes(15), Jun Wang(15), Trine Nielsen(13), Joël Doré(13), Shinichi Sunagawa(13), Junhua Li(12), Henrik Bjørn Nielsen(11), Søren Brunak(11), Karsten Kristiansen(11), Oluf Pedersen(11), Aleksander Krag(10), Florence Levenez(9), Takuji Yamada(9), Daniel R. Mende(9), Dan Knights(8), Nicola Segata(8), Jens Roat Kultima(8), Ruth E. Ley(7)